Anlotinib and Irinotecan for Ewing Sarcoma

NCT03416517 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Ewing's Tumor Metastatic

Interventions

DRUG: Anlotinib
DRUG: Irinotecan

Sponsor

Peking University People's Hospital